Understanding the hepatitis C virus life cycle paves the way for highly effective therapies.
about
Direct-acting antivirals for chronic hepatitis CGenetic dissection of Flaviviridae host factors through genome-scale CRISPR screensHepatitis C Viral Infection in Children: Updated ReviewSafety and efficacy of daclatasvir in the management of patients with chronic hepatitis CHepatitis C Virus Infection Induces Autophagy as a Prosurvival Mechanism to Alleviate Hepatic ER-Stress ResponseInterferon-Free Treatments for Chronic Hepatitis C Genotype 1 InfectionHepatitis C virus relies on lipoproteins for its life cycleChaperones in hepatitis C virus infectionSignificance of hepatitis virus infection in the oncogenic initiation of hepatocellular carcinomaNatural killer cells in hepatitis C: Current progressVirologic Tools for HCV Drug Resistance TestingImmune and non-immune responses to hepatitis C virus infectionInhibitors of the Hepatitis C Virus Polymerase; Mode of Action and ResistanceChronic hepatitis C virus infection and lipoprotein metabolismNew treatment strategies for hepatitis C infectionEmerging therapies for hepatitis CImmune responses to HCV and other hepatitis virusesStudying the immune response to human viral infections using zebrafishT cell responses in hepatitis C virus infection: historical overview and goals for future researchDaclatasvir: potential role in hepatitis CConditional Inducible Triple-Transgenic Mouse Model for Rapid Real-Time Detection of HCV NS3/4A Protease ActivityProduction of infectious HCV genotype 1b virus in cell culture using a novel Set of adaptive mutationsCombinations of siRNAs against La Autoantigen with NS5B or hVAP-A Have Additive Effect on Inhibition of HCV ReplicationCell-death-inducing DFFA-like Effector B Contributes to the Assembly of Hepatitis C Virus (HCV) Particles and Interacts with HCV NS5ADaclatasvir combined with peginterferon-α and ribavirin for the treatment of chronic hepatitis C: a meta-analysisHepatitis C virus: Virology, diagnosis and treatmentSurveying the global virome: identification and characterization of HCV-related animal hepacivirusesEnhancing our understanding of current therapies for hepatitis C virus (HCV)A quantitative high-resolution genetic profile rapidly identifies sequence determinants of hepatitis C viral fitness and drug sensitivityCasein kinase II inhibitor enhances production of infectious genotype 1a hepatitis C virus (H77S)The inhibitory effects of anacardic acid on hepatitis C virus life cycleXRN1 stalling in the 5' UTR of Hepatitis C virus and Bovine Viral Diarrhea virus is associated with dysregulated host mRNA stabilityRational Design and Adaptive Management of Combination Therapies for Hepatitis C Virus InfectionA CRISPR toolbox to study virus-host interactionsHepatitis C virus NS5A protein blocks epidermal growth factor receptor degradation via a proline motif- dependent interactionShort-Sighted Virus Evolution and a Germline Hypothesis for Chronic Viral Infections.Sofosbuvir/velpatasvir regimen promises an effective pan-genotypic hepatitis C virus cure.Hepatitis C virus infection.The impact of the revolution in hepatitis C treatment on hepatocellular carcinoma.Characterization of nonprimate hepacivirus and construction of a functional molecular clone
P2860
Q24185977-49850374-8509-447C-9AF4-B08F2CCF3867Q24705236-4A4D297C-22E6-416B-9744-566508057907Q26738856-648FC507-ABC4-462F-8C70-3CDEBE7312AAQ26745769-FCC605FC-1373-4EF3-97BE-DDC0DCAD2062Q26745984-128EB3BC-38D8-4FD1-AFE7-63E2DE60540CQ26746563-90EEE08E-B323-432D-BDDC-3A61F05CF25EQ26766119-4A1EDAB6-CAF5-4DC4-8BB6-AEFB7D89CEA9Q26771251-9F99577E-E65D-4B7B-96E9-E8C45CAAB2CCQ26773251-BE0950CA-A15B-4149-BC6D-F36E6F2D1CA8Q26773264-999ED1B2-BA71-4AED-8A4D-32496C73164BQ26774374-D940E5B4-DA03-420B-86D7-A4517475EF03Q26782040-094A71E2-235E-47E8-99C1-48D1EC8D7833Q26783056-42C81729-7AE4-4643-8439-500831174665Q26784234-EC5FE488-A9B2-4D2B-AB8E-51DF385E725DQ26795407-DD8F8842-8024-4842-B351-D27473625B6FQ26853642-5D490B0E-869C-4477-84D9-BE014B106810Q26866955-A5F2F938-842E-4E4C-AF28-FE9FD7ECAF93Q27002635-6636D877-5E2C-49FB-BA35-B758F045BABCQ27003510-C8D7685B-2705-4827-BE2B-58F8CD28E28CQ27012741-5B8821B8-BACC-43FF-B7DA-8ED2E15ACCCEQ27318504-E9EBF660-995C-433C-B971-0DC6F0E236E6Q27468653-72DBAAB9-8184-4EF6-9DDD-FDA54715B2E5Q27469011-200BFE71-03F5-4B36-85DA-9E00FF1BF6CBQ27469080-14571F41-B066-45B9-A7D2-7A83B1113DA5Q28073108-0ECB47CA-965E-4265-9290-012D5D90C81EQ28082000-13291B1A-55DC-4667-BE28-96D216925496Q28084946-E644648E-ACA0-45E4-A170-D59522419600Q28085718-F69DD3CE-C1C7-40F6-A75F-4EF7A5FBAC83Q28537708-EFE97312-0AA7-4CEA-BE61-345CFEF1BDFDQ28542410-3F6364F5-A2DC-436E-BF1A-600F7ACE74F7Q28543293-E1BFEA1A-9DF0-440C-A838-A87DE4F15901Q28543912-27128B13-F3E0-4A53-B2AF-31DF777D05E8Q28545971-78092752-E145-4EC1-843C-844DE9CCC265Q29994612-07A08E83-5456-4796-A179-68AFFFA4E9AAQ30009188-44D41E13-B770-4F5E-8ADD-9A4A15996992Q30234948-A48D7AD1-408C-4ED6-84BD-513CB48A9C67Q30235430-63DE106A-03BF-4EB2-8985-396EA7C4EBCFQ30235491-8B64D10B-6F70-4F1F-8F4E-A135F7EDD63AQ30250096-94CF50A5-B7D8-4E6F-802D-E0CCE5160951Q30622630-D1553A5A-A312-4F97-8E43-373109CA622A
P2860
Understanding the hepatitis C virus life cycle paves the way for highly effective therapies.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Understanding the hepatitis C ...... or highly effective therapies.
@en
Understanding the hepatitis C ...... or highly effective therapies.
@nl
type
label
Understanding the hepatitis C ...... or highly effective therapies.
@en
Understanding the hepatitis C ...... or highly effective therapies.
@nl
prefLabel
Understanding the hepatitis C ...... or highly effective therapies.
@en
Understanding the hepatitis C ...... or highly effective therapies.
@nl
P2860
P356
P1433
P1476
Understanding the hepatitis C ...... for highly effective therapies
@en
P2093
Charles M Rice
P2860
P2888
P304
P356
10.1038/NM.3248
P407
P577
2013-07-01T00:00:00Z